Literature DB >> 11221708

Cancer multidrug resistance.

.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11221708

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  18 in total

1.  Vitamin E reverses multidrug resistance in vitro and in vivo.

Authors:  Jingling Tang; Qiang Fu; Yongjun Wang; Kelly Racette; Dun Wang; Feng Liu
Journal:  Cancer Lett       Date:  2013-04-23       Impact factor: 8.679

Review 2.  Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy.

Authors:  Ziyin Huang; Cassandra E Callmann; Shuya Wang; Matthew K Vasher; Michael Evangelopoulos; Sarah Hurst Petrosko; Chad A Mirkin
Journal:  ACS Cent Sci       Date:  2022-05-20       Impact factor: 18.728

3.  A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.

Authors:  Ana Catarina Alves; Daniela Ribeiro; Miguel Horta; José L F C Lima; Cláudia Nunes; Salette Reis
Journal:  J R Soc Interface       Date:  2017-08       Impact factor: 4.118

4.  Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.

Authors:  Mar Creixell; Nicholas A Peppas
Journal:  Nano Today       Date:  2012-08-01       Impact factor: 20.722

Review 5.  Technologies for deriving primary tumor cells for use in personalized cancer therapy.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Trends Biotechnol       Date:  2013-04-16       Impact factor: 19.536

Review 6.  Molecular targeted α-particle therapy for oncologic applications.

Authors:  Thaddeus J Wadas; Darpan N Pandya; Kiran Kumar Solingapuram Sai; Akiva Mintz
Journal:  AJR Am J Roentgenol       Date:  2014-08       Impact factor: 3.959

7.  Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells.

Authors:  Wenzhe Ma; Senling Feng; Xiaojun Yao; Zhongwen Yuan; Liang Liu; Ying Xie
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

8.  Thymidylate synthase expression determines pemetrexed targets and resistance development in tumour cells.

Authors:  Aitziber Buqué; Unai Aresti; Begoña Calvo; Jangi Sh Muhialdin; Alberto Muñoz; Sergio Carrera; Eider Azkona; Itziar Rubio; Guillermo López-Vivanco
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

Review 9.  Inorganic nanolayers: structure, preparation, and biomedical applications.

Authors:  Bullo Saifullah; Mohd Zobir B Hussein
Journal:  Int J Nanomedicine       Date:  2015-09-02

10.  Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?

Authors:  João Conde; Jesús M de la Fuente; Pedro V Baptista
Journal:  Front Pharmacol       Date:  2013-10-25       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.